Atika Capital Management’s Allergan plc AGN Stock Holding History

Atika Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,500	Closed	-$4.66M	–	93
2017 Q1	$4.66M	Buy	19,500 +5,000	+34%	+$1.16M	2.28%	10
2016 Q4	$3.04M	Buy	+14,500	New	+$3M	1.81%	23
2016 Q3	–	Sell	-25,000	Closed	-$5.78M	–	83
2016 Q2	$5.78M	Buy	25,000 +20,000	+400%	+$4.61M	2.47%	11
2016 Q1	$1.34M	Sell	5,000 -16,090	-76%	-$4.61M	0.81%	40
2015 Q4	$6.59M	Buy	21,090 +1,090	+5%	+$325K	3.39%	7
2015 Q3	$5.44M	Sell	20,000 -6,150	-24%	-$1.89M	2.67%	14
2015 Q2	$7.94M	Buy	26,150 +2,150	+9%	+$641K	3.57%	6
2015 Q1	$7.14M	Buy	24,000 +3,075	+15%	+$877K	4.77%	1
2014 Q4	$5.39M	Buy	20,925 +915	+5%	+$229K	3.94%	3
2014 Q3	$4.83M	Buy	20,010 +12,510	+167%	+$2.8M	3.71%	3
2014 Q2	$1.67M	Buy	+7,500	New	+$1.55M	1.36%	34

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Atika Capital Management's AGN Position: Q2 2017 in Review

Atika Capital Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 19,500 shares — an estimated $4.66M sold.

Atika Capital Management first reported a position in AGN in Q2 2014 and held it in 11 quarters. The position peaked at $7.94M in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

Atika Capital Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
Atika Capital Management sold 19,500 Allergan plc shares in Q2 2017, an estimated $4.66M.
Atika Capital Management first reported a position in Allergan plc in Q2 2014 and held it in 11 quarters.
Atika Capital Management's Allergan plc position peaked at $7.94M in Q2 2015.
1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Atika Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.